Bio-Rad Laboratories Inc (BIO)
279.40
-1.62
(-0.58%)
USD |
NYSE |
Apr 19, 16:00
279.40
0.00 (0.00%)
After-Hours: 20:00
Bio-Rad Laboratories Free Cash Flow (Quarterly): 38.80M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 38.80M |
| September 30, 2023 | 53.64M |
| June 30, 2023 | 63.43M |
| March 31, 2023 | 62.39M |
| December 31, 2022 | 43.49M |
| September 30, 2022 | -16.55M |
| June 30, 2022 | 35.94M |
| March 31, 2022 | 17.42M |
| December 31, 2021 | 114.68M |
| September 30, 2021 | 195.74M |
| June 30, 2021 | 131.24M |
| March 31, 2021 | 94.06M |
| December 31, 2020 | 245.60M |
| September 30, 2020 | 115.69M |
| June 30, 2020 | 74.01M |
| March 31, 2020 | 41.12M |
| December 31, 2019 | 138.20M |
| September 30, 2019 | 68.66M |
| June 30, 2019 | 133.19M |
| March 31, 2019 | 19.31M |
| December 31, 2018 | 51.14M |
| September 30, 2018 | 40.22M |
| June 30, 2018 | 51.15M |
| March 31, 2018 | 13.16M |
| December 31, 2017 | 43.29M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.292M |
| June 30, 2017 | 32.96M |
| March 31, 2017 | -95.54M |
| December 31, 2016 | 49.51M |
| September 30, 2016 | 12.15M |
| June 30, 2016 | 45.58M |
| March 31, 2016 | -32.74M |
| December 31, 2015 | 7.968M |
| September 30, 2015 | 57.48M |
| June 30, 2015 | 6.33M |
| March 31, 2015 | 1.059M |
| December 31, 2014 | 0.091M |
| September 30, 2014 | 63.19M |
| June 30, 2014 | 42.92M |
| March 31, 2014 | 30.63M |
| December 31, 2013 | 42.63M |
| September 30, 2013 | 34.49M |
| June 30, 2013 | -4.795M |
| March 31, 2013 | -10.55M |
| December 31, 2012 | 55.68M |
| September 30, 2012 | 34.18M |
| June 30, 2012 | 31.61M |
| March 31, 2012 | 0.361M |
| December 31, 2011 | 45.84M |
| September 30, 2011 | 26.19M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-16.55M
Minimum
Sep 2022
245.60M
Maximum
Dec 2020
86.88M
Average
68.66M
Median
Sep 2019
Free Cash Flow (Quarterly) Benchmarks
| Agilent Technologies Inc | 395.00M |
| Bruker Corp | 174.00M |
| Azenta Inc | 14.51M |
| Harvard Bioscience Inc | 3.242M |
| Bionano Genomics Inc | -30.52M |